We offer specialized services for the isolation of Peripheral Blood Mononuclear Cells (PBMCs) and the development of patient-specific induced Pluripotent Stem Cells (iPSCs). These services support personalized medicine by enabling tailored disease modeling and therapeutic applications.
Our PBMCs are isolated from human whole blood using standardized density gradient centrifugation techniques, ensuring optimal cell viability and purity.
Our goal is to support your most ambitious scientific goals with high-quality cellular tools designed to accelerate breakthroughs in precision medicine and immuno-oncology.
Our iPSCs are reprogrammed from PBMCs under GMP-compliant conditions, offering a renewable and versatile cell source for personalized and regenerative medicine.